...
首页> 外文期刊>Respiratory care clinics of North America >Tissue diagnosis of suspected lung cancer: selecting between bronchoscopy, transthoracic needle aspiration, and resectional biopsy.
【24h】

Tissue diagnosis of suspected lung cancer: selecting between bronchoscopy, transthoracic needle aspiration, and resectional biopsy.

机译:疑似肺癌的组织诊断:在支气管镜检查,经胸针抽吸和切除活检之间进行选择。

获取原文
获取原文并翻译 | 示例
           

摘要

In pursuing a tissue diagnosis of a suspected lung cancer, there is a range of procedures to choose from. The principal goals are ideally to diagnose and pathologically stage the patient's lung cancer at the same time, preferably by using the safest, least invasive, and least costly tests. If there is clinical or radiographic evidence of extrapulmonary spread of disease, including supraclavicular N3 nodal involvement or a malignant pleural effusion, then radiology-guided or open biopsy will confirm tumor cell type and stage the patient as unresectable. For patients with symptoms, such as increasing cough or hemoptysis, that are suggestive of airways involvement. with or without radiographic finding of central lesions, sputum cytology is the least invasive study with a high specificity. A positive finding of cancer is especially helpful if the patient is not a surgical candidate because of anatomic location of the lesion or severe physiologic limitations. The limited sensitivity of sputum cytology and poor NPV may improve with improved sputum induction and collection and processing techniques. Bronchoscopy with direct examination of the visible airways is most often the preferred invasive diagnostic procedure. Although the procedure should be geared toward sampling the highest staged lesion to provide an accurate tissue staging at the time of diagnosis, additional procedures can be performed in sequence to sample different nodal stations, is well as the primary lung mass. The incidental finding of an unexpected central airways lesions or a synchronous second endobronchial lung primary will also affect plans for treatment. Autofluorescence bronchoscopy can improve the sensitivity for detecting early intraepithelial neoplasia. Bronchoscopy for central and peripheral lung masses that are suspected to be lung cancer should be performed with ROSE whenever available. For visible endobronchial lesions, given the similar yield of EBBX and EBNA, EBNA may provide an immediate diagnosis, thus obviating additional, possibly morbid, procedures such as BB or EBBX. For submucosal lesions, EBNA is superior. For central cancers that are peribronchial, TBNA performed as for regional nodal sampling should have a yield that is comparable to TBNA for staging. TBBX and TBNA of peripheral nodules that are smaller than 3 cm have a lower diagnostic yield. Coming generations of thin bronchoscopes and improved radiographic guidance systems may improve our ability to biopsy these lesions with greater accuracy and safety. Under all circumstances, immediate cytology feedback with ROSE will confirm the adequacy of the retrieved specimen for a definitive tissue diagnosis, thus avoiding the need for extra biopsies, or worse yet, the need for a second invasive procedure because of insufficient diagnostic material. ROSE is educational to the clinician and fellow-in-training in getting immediate feedback on the procedural techniques and in learning pulmonary pathology, as well. The diagnostic sensitivity of TTNA is high, especially for the larger peripheral-based lung lesion, and TTNA is a relatively rapid procedure. TTNA's sensitivity falls for smaller or more central lesions, where the false negative rate can approach 25% to 30%; the risk of pneumothoraces and bleeding increases with central biopsies. Furthermore, TTNA usually does not provide information about nodal staging, unless the TTNA is initially directed toward central lymph nodes. The central airways are not examined in the same appointment to address issues of resection margins when there may be central spread of disease. TTNA should, therefore, be held in reserve for cases in which the sputum cytology and subsequent bronchoscopy are negative, and the patient is not a surgical candidate or refuses surgery, even if the cancer is potentially resectable. TTNA may then provide the tissue diagnosis to permit initiation of cytotoxic chemotherapy and radiotherapy. TTNA may also be helpful in cases where the
机译:在进行可疑肺癌的组织诊断时,有多种方法可供选择。理想的主要目标是同时诊断和病理分期患者的肺癌,最好使用最安全,侵入性最小,成本最低的测试。如果有临床或影像学证据表明肺外疾病扩散,包括锁骨上N3淋巴结转移或恶性胸腔积液,则放射学指导或开放式活检将确认肿瘤细胞类型并将患者分期为无法切除。对于症状如咳嗽或咯血加重的患者,提示气道受累。无论有无中央部影像学发现,痰细胞学检查都是具有高特异性的侵入性最小的研究。如果患者由于病变的解剖位置或严重的生理限制而不适合做外科手术,则对癌症的阳性发现尤其有帮助。痰细胞学敏感性有限和NPV差可通过改善痰诱导,收集和处理技术来改善。直接检查可见气道的支气管镜检查通常是首选的侵入性诊断程序。尽管该程序应适合于对最高分期的病变进行采样,以在诊断时提供准确的组织分期,但可以依次执行其他程序以采样不同的结节以及原发性肺部肿块。偶然发现意外的中央气道病变或同步的第二支气管内肺原发也会影响治疗计划。自体荧光支气管镜检查可以提高检测早期上皮内瘤变的敏感性。如有可能,应使用ROSE进行怀疑为肺癌的中央和周围肺肿块的支气管镜检查。对于可见的支气管内病变,考虑到EBBX和EBNA的产量相似,EBNA可以提供即时诊断,从而避免了额外的可能病态的操作,例如BB或EBBX。对于粘膜下病变,EBNA更好。对于支气管周围的中心癌,按区域淋巴结取样进行的TBNA分期应与TBNA相当。小于3 cm的周围结节的TBBX和TBNA诊断率较低。新一代的细支气管镜和改进的射线照相引导系统可能会提高我们对这些病变进行活检的能力,从而具有更高的准确性和安全性。在任何情况下,使用ROSE进行的即时细胞学反馈都将确认所取回的标本足以用于确定的组织诊断,从而避免了需要额外的活检或更糟糕的是,由于诊断材料不足而需要进行第二次侵入性检查。 ROSE对临床医生和在职培训人员具有教育意义,可获取有关程序技术的即​​时反馈以及学习肺部病理学的信息。 TTNA的诊断敏感性很高,尤其是对于较大的周围型肺部病变,并且TTNA是相对快速的过程。 TTNA对较小或更多中央病变的敏感性下降,假阴性率可能接近25%到30%。中央活检会增加气胸和出血的风险。此外,除非TTNA最初针对中央淋巴结,否则TTNA通常不提供有关淋巴结分期的信息。当可能出现疾病的中心扩散时,不在同一约会中检查中央气道以解决切除切缘的问题。因此,如果痰细胞学检查和随后的支气管镜检查结果均为阴性,并且即使癌症可能会切除,患者也不是手术候选人或拒绝手术,则应保留TTNA。 TTNA然后可以提供组织诊断以允许开始细胞毒性化学疗法和放射疗法。在以下情况下,TTNA也可能会有所帮助:

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号